Holen Sie sich die Stockscreener-App
4.11
10.85%
-0.50
Handel nachbörslich:
4.14
0.03
+0.73%
Adc Therapeutics Sa Aktie (ADCT) Neueste Nachrichten
What insider trading reveals about ADC Therapeutics SA stockIPO Watch & Risk Controlled Swing Alerts - newser.com
Wealth Enhancement Advisory Services LLC Sells 3,758 Shares of ADC Therapeutics SA $ADCT - Defense World
ADC Therapeutics SA announced that it expects to receive $60.02 million in funding - MarketScreener
Should you wait for a breakout in ADC Therapeutics SAEarnings Overview Summary & AI Forecast Swing Trade Picks - newser.com
ADC Therapeutics rises on $60M PIPE financing - MSN
ADC Therapeutics raises $60 million in private placement financing - Investing.com India
ADC Therapeutics raises $60 million in private placement financing By Investing.com - Investing.com Nigeria
ADC Therapeutics Announces $60 Million Private Placement - PR Newswire
Visual analytics tools that track ADC Therapeutics SA performanceQuarterly Growth Report & Detailed Earnings Play Alerts - newser.com
Published on: 2025-10-13 01:51:42 - newser.com
Published on: 2025-10-12 23:16:07 - newser.com
Using flow based indicators on ADC Therapeutics SAJuly 2025 Technicals & Fast Exit Strategy with Risk Control - newser.com
What technical models suggest about ADC Therapeutics SA’s comeback2025 Short Interest & Fast Gaining Stock Reports - newser.com
Key metrics from ADC Therapeutics SA’s quarterly dataPortfolio Update Report & Low Risk Investment Opportunities - newser.com
Risk adjusted return profile for ADC Therapeutics SA analyzedJuly 2025 EndofMonth & Verified Technical Signals - newser.com
Weiss Ratings Reiterates “Sell (D-)” Rating for ADC Therapeutics (NYSE:ADCT) - Defense World
Using R and stats models for ADC Therapeutics SA forecastingMarket Growth Summary & Safe Capital Investment Plans - newser.com
What hedge fund moves indicate for ADC Therapeutics SA Common Shares stockMarket Growth Report & Daily Market Momentum Tracking - newser.com
ADC Therapeutics SA stock daily chart insightsJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
ADC Therapeutics (NYSE:ADCT) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
ADC Therapeutics SA (NYSE:ADCT) Receives $7.75 Consensus PT from Brokerages - Defense World
ADC Therapeutics SA Hits New 52-Week High of $4.67 - Markets Mojo
ADC Therapeutics SA (NYSE:ADCT) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - 富途牛牛
ADC Therapeutics Gains Ground Ahead Of LOTIS-7 Expansion, LOTIS-5 Readout - RTTNews
ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts - MSN
Analysts Offer Predictions for ADCT Q3 Earnings - Defense World
ADC Therapeutics SA Hits New 52-Week High of USD 4.31 - Markets Mojo
ADC Therapeutics (NYSE:ADCT) Sets New 52-Week HighStill a Buy? - MarketBeat
Order flow analysis tools used on ADC Therapeutics SAEntry Point & Low Drawdown Trading Strategies - newser.com
Understanding ADC Therapeutics SA’s price movementTrade Risk Assessment & Daily Technical Forecast Reports - newser.com
Analyzing recovery setups for ADC Therapeutics SA investorsMarket Risk Summary & Stepwise Trade Execution Plans - newser.com
Why analysts maintain buy rating on ADC Therapeutics SA Common Shares stock2025 Market Overview & Daily Risk Controlled Trade Plans - newser.com
ADC Therapeutics SA (NYSE:ADCT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
What is the fair value estimate for ADC Therapeutics SA Common Shares stock in 2025Take Profit & Fast Momentum Entry Tips - newser.com
Intraday pattern recognizer results for ADC Therapeutics SAPortfolio Risk Summary & Verified Entry Point Signals - newser.com
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):